(Q60200036)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

title

Aberrations of the Chk2 tumour suppressor in advanced urinary bladder cancer (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

9

Jiri Bartek

1 reference

1 January 2020

Per Guldberg

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Karen Koed

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Hanne Primdahl

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Klaus Møller

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Torben F Ørntoft

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Jirina Bartkova

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

Kirsten Grønbaek

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

language of work or name

English

0 references

publication date

1 November 2004

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

volume

23

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

issue

52

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

page(s)

8545-8551

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/sj.onc.1207878

1 January 2020

exact match

0 references

cites work

Cell cycle checkpoint signaling through the ATM and ATR kinases

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Phosphorylation of threonine 68 promotes oligomerization and autophosphorylation of the Chk2 protein kinase via the forkhead-associated domain

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

CHK2 kinase--a busy messenger.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Mammalian G1- and S-phase checkpoints in response to DNA damage

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Chk1 and Chk2 kinases in checkpoint control and cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Chk2 tumour suppressor protein in human spermatogenesis and testicular germ-cell tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Heterozygous germ line hCHK2 mutations in Li-Fraumeni syndrome

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Allosteric effects mediate CHK2 phosphorylation of the p53 transactivation domain.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

A DNA damage checkpoint response in telomere-initiated senescence

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

53BP1 functions in an ATM-dependent checkpoint pathway that is constitutively activated in human cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Mutations in CHEK2 associated with prostate cancer risk

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Functional impact of concomitant versus alternative defects in the Chk2-p53 tumour suppressor pathway.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

ATM mutations are associated with inactivation of the ARF-TP53 tumor suppressor pathway in diffuse large B-cell lymphoma

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Mutations of Chk2 in primary hematopoietic neoplasms

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Chk2 is a tumor suppressor that regulates apoptosis in both an ataxia telangiectasia mutated (ATM)-dependent and an ATM-independent manner

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

DNA damage-induced activation of p53 by the checkpoint kinase Chk2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Genome maintenance mechanisms for preventing cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Mutation analysis of the DNA-damage checkpoint gene CHK2 in myelodysplastic syndromes and acute myeloid leukemias

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

The many substrates and functions of ATM

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

DNA double-strand breaks: signaling, repair and the cancer connection

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Low-penetrance susceptibility to breast cancer due to CHEK2(*)1100delC in noncarriers of BRCA1 or BRCA2 mutations

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Threonine 68 is required for radiation-induced phosphorylation and activation of Cds1.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Mutations of the CHK2 gene are found in some osteosarcomas, but are rare in breast, lung, and ovarian tumors

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Analysis of CHK2 in vulval neoplasia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Variants in CHEK2 other than 1100delC do not make a major contribution to breast cancer susceptibility

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

CHEK2 variants associate with hereditary prostate cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

CHEK2 variants in susceptibility to breast cancer and evidence of retention of the wild type allele in tumours

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

A robust method for detecting CHK2/RAD53 mutations in genomic DNA.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Concomitant inactivation of p53 and Chk2 in breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Chk2-deficient mice exhibit radioresistance and defective p53-mediated transcription

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

DNA damage foci at dysfunctional telomeres

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Analysis of the CHK2 gene in lymphoid malignancies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

CHK2-decreased protein expression and infrequent genetic alterations mainly occur in aggressive types of non-Hodgkin lymphomas

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Chk2 activation and phosphorylation-dependent oligomerization

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Arf tumor suppressor promoter monitors latent oncogenic signals in vivo

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1207878

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1207878

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15361851%20AND%20SRC:MED&resulttype=core&format=json

1 January 2020

1 reference